Litigation Watch: ARTHRITIS DRUGS is a monthly newsletter for attorneys, focusing on drugs used to treat osteo and rheumatoid arthritis: Arava, Enbrel, Remicade, Humira, Vioxx, Celebrex and more. These drugs are already the subject of litigation following claims that they cause everything from liver damage to cancer, heart failure and strokes. Each issue features case news, interviews, legislative and FDA updates, and reviews from current medical literature.
Arthritis Drugs - Issue: 14
Vioxx Plaintiff Wants Merck's Dose, Naproxen Testimony Excluded
Application Made to Designate Bextra as Mass Tort in New Jersey
Pharmacy Says It Can't Be Held Liable for Plaintiff's Celebrex Injury Claims
3rd Calif. Judge Replaced; New Judge Didn't Take Vioxx, But Takes Celebrex
Parties Enter Tolling Agreement for Vioxx Cardiovascular Claims Filed in Federal Court
Vioxx Judge Allows Communications with Plaintiffs' Physicians, But with Proper Notice
Merck Files Motion to Consolidate Texas State Court Vioxx Litigation
Arthritis Drugs - Issue: 13
Arthritis Drugs In the Medical Literature This Month
